Peer review Peer review information Nature Medicine thanks Louis Aronne, Carina Oehrn and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
However, the common requirement for all pharmacies is that any custom formulation of tirzepatide must be supported by a well-documented patient need
Scientific References Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics
Key points: Gastrointestinal side effects became more common as the dose rose in STEP UP, from 42.8% on placebo to 61.2% on 2.4 mg and 70.8% on 7.2 mg Altered skin sensations, such as tingling, were also more common on 7.2 mg (22.9%) than on 2.4 mg (6.0%) Nausea, diarrhoea, vomiting, and constipation are the most common side effects Side effects are usually worst just after a dose increase and often settle within a few weeks Its worth considering whether increasing the dose is worth the risk of increased side effects
This was consistent with reduced butanoate metabolism